SPOTLIGHT -
6-Week Natalizumab Dosing Efficacious, MS Cognitive Perceptions, Glatiramer Acetate Depot Shines in Progressive MS
Neurology News Network for the week ending June 11, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — June 10, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 10, 2022.
This Week on NeurologyLive® — June 6, 2022
Here's what is coming soon to NeurologyLive®.
NeurologyLive® Friday 5 — June 3, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 3, 2022.
Inaugural Class of Giants of Multiple Sclerosis Announced
The 1st annual awards ceremony was held during the CMSC Annual Meeting in National Harbor, Maryland.
This Week on NeurologyLive® — May 30, 2022
AbbVie Submits NDA for ABBV-951, Periconceptional Folic Acid Supplementation Lowers Preterm Birth Risk, FDA Accepts NDA for Zavegepant
Neurology News Network for the week ending May 28, 2022.
NeurologyLive® Friday 5 — May 27, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 27, 2022.
This Week on NeurologyLive® — May 23, 2022
Diazepam Increased Time Between Cluster Intervals, Higher Dose Nusinersen Shows Extra Benefit, Lecanemab BLA Submitted
Neurology News Network for the week ending May 21, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — May 20, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 20, 2022.
This Week on NeurologyLive® — May 16, 2022
Ravulizumab Meets Primary End Point in NMOSD, Dosing Initiated in TRANQUILITY II Study, NIH Launches EBV Vaccine Trial
Neurology News Network for the week ending May 14, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — May 13, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 13, 2022.
This Week on NeurologyLive® — May 9, 2022
Risdiplam Shows Safety at 3-Year Period, FDA Issues CRL for AXS-07, Cognitive Tests Improve Responder Profiles in MS
Neurology News Network for the week ending May 7, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — May 6, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 6, 2022.
This Week on NeurologyLive® — May 2, 2022
Pitolisant Being Evaluated for Idiopathic Hypersomnia, FDA Approves Ravulizumab for Generalized Myasthenia Gravis, Gender Differences in MS Disease Activity
Neurology News Network for the week ending April 30, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — April 29, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 29, 2022.
This Week on NeurologyLive® — April 25, 2022
Risk Factors Identified for Posttraumatic Seizures, Acupuncture Benefits in Insomnia, Erenumab Improves Migraine in Patients Unresponsive to Prophylactics
Neurology News Network for the week ending April 23, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — April 22, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 22, 2022.
This Week on NeurologyLive® — April 18, 2022
Vutrisiran FDA Decision Extended, Gamma Sensory Stimulation Shows Benefit in Alzheimer, DBS Programming Software Greenlit
Neurology News Network for the week ending April 16, 2022 [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — April 15, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 15, 2022.
This Week on NeurologyLive® — April 11, 2022
Once-Nightly Sodium Oxybate Preferred in Narcolepsy, ABBV-951 Shines in PD, Ocrelizumab Demonstrates Improved Cognitive Function in Progressive MS
Neurology News Network for the week ending April 9, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — April 8, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 8, 2022.
This Week on NeurologyLive® — April 4, 2022
